assembly Bill A128

Signed By Governor
2021-2022 Legislative Session

Establishes an online directory for distributors of opioid antagonists

download bill text pdf

Sponsored By

Current Bill Status Via S6044 - Signed by Governor


  • Introduced
  • In Committee
  • On Floor Calendar
    • Passed Senate
    • Passed Assembly
  • Delivered to Governor
  • Signed by Governor

Your Voice

do you support this bill?

Please enter your contact information

Home address is used to determine the senate district in which you reside. Your support or opposition to this bill is then shared immediately with the senator who represents you.

Optional services from the NY State Senate:

Create an account. An account allows you to officially support or oppose key legislation, sign petitions with a single click, and follow issues, committees, and bills that matter to you. When you create an account, you agree to this platform's terms of participation.

Include a custom message for your Senator? (Optional)

Enter a message to your senator. Many New Yorkers use this to share the reasoning behind their support or opposition to the bill. Others might share a personal anecdote about how the bill would affect them or people they care about.

Actions

view actions (12)
Assembly Actions - Lowercase
Senate Actions - UPPERCASE
Oct 07, 2021 signed chap.434
Oct 06, 2021 delivered to governor
Jun 07, 2021 returned to senate
passed assembly
ordered to third reading rules cal.405
substituted for a128
Jun 07, 2021 substituted by s6044
rules report cal.405
reported
Jun 03, 2021 reported referred to rules
May 24, 2021 reported referred to ways and means
Jan 06, 2021 referred to alcoholism and drug abuse

Co-Sponsors

A128 (ACTIVE) - Details

See Senate Version of this Bill:
S6044
Law Section:
Mental Hygiene Law
Laws Affected:
Amd §19.09, Ment Hyg L
Versions Introduced in Other Legislative Sessions:
2017-2018: A10991
2019-2020: A307, S4499

A128 (ACTIVE) - Summary

Directs the office of addiction services and supports to maintain an online directory of distributors of opioid antagonists.

A128 (ACTIVE) - Bill Text download pdf

 
                     S T A T E   O F   N E W   Y O R K
 ________________________________________________________________________
 
                                    128
 
                        2021-2022 Regular Sessions
 
                           I N  A S S E M B L Y
 
                                (PREFILED)
 
                              January 6, 2021
                                ___________
 
 Introduced  by  M.  of  A. L. ROSENTHAL, STIRPE, REILLY -- read once and
   referred to the Committee on Alcoholism and Drug Abuse
 
 AN ACT to amend the mental hygiene law, in  relation  to  requiring  the
   office of addiction services and supports to maintain an online direc-
   tory of distributors of opioid antagonists
 
   THE  PEOPLE OF THE STATE OF NEW YORK, REPRESENTED IN SENATE AND ASSEM-
 BLY, DO ENACT AS FOLLOWS:
 
   Section 1. Section 19.09 of the  mental  hygiene  law  is  amended  by
 adding a new subdivision (l) to read as follows:
   (L)(1)  THE  OFFICE,  IN  CONSULTATION  WITH THE DEPARTMENT OF HEALTH,
 SHALL MAINTAIN ON ITS WEBSITE A  PUBLICLY  AVAILABLE  DIRECTORY  OF  ALL
 DISTRIBUTORS  OF  OPIOID  ANTAGONISTS  TO  THE PUBLIC, INCLUDING BUT NOT
 LIMITED TO, PHARMACIES, PREVENTION PROGRAMS AND NOT-FOR-PROFITS. AS USED
 IN THIS SUBDIVISION, THE FOLLOWING TERMS SHALL HAVE THE FOLLOWING  MEAN-
 INGS:
   (I)  "OPIOID"  MEANS  AN  OPIATE  AS  DEFINED  IN SECTION THIRTY-THREE
 HUNDRED TWO OF THE PUBLIC HEALTH LAW.
   (II) "OPIOID ANTAGONIST" MEANS A FEDERAL  FOOD  AND  DRUG  ADMINISTRA-
 TION-APPROVED  DRUG  THAT,  WHEN ADMINISTERED, NEGATES OR NEUTRALIZES IN
 WHOLE OR IN PART THE PHARMACOLOGICAL EFFECTS OF AN OPIOID IN  THE  BODY.
 THE  OPIOID ANTAGONIST SHALL BE LIMITED TO NALOXONE OR OTHER MEDICATIONS
 APPROVED BY THE DEPARTMENT OF HEALTH FOR THIS PURPOSE.
   (2) THE DIRECTORY REQUIRED BY THIS SUBDIVISION SHALL  INCLUDE  AND  BE
 SEARCHABLE BY THE FOLLOWING INFORMATION:
   (I) ADDRESSES OF EACH DISTRIBUTOR OF OPIOID ANTAGONISTS;
   (II)  CONTACT  INFORMATION,  SUCH AS PHONE NUMBERS OR EMAIL ADDRESSES,
 FOR EACH DISTRIBUTOR;
   (III) SERVICES OFFERED BY EACH DISTRIBUTOR AT EACH  LOCATION  IF  MORE
 THAN  ONE, AS WELL AS INFORMATION PROVIDING WHICH OPIOID ANTAGONISTS ARE
 CURRENTLY AVAILABLE AT EACH DISTRIBUTOR;
 
  EXPLANATION--Matter in ITALICS (underscored) is new; matter in brackets